Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores

Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores

Background: There is still little knowledge about the association of liver fibrosis with the clinical outcomes of COVID-19 patients with non-alcoholic fatty liver disease (NAFLD). The aim of the study was to determine the association of NAFLD fibrosis score (NFS)–determined liver fibrosis with clini...

Full description

Bibliographic Details
Main Authors: Cheng, J. (Author), Huang, R. (Author), Huang, S. (Author), Li, C. (Author), Li, M. (Author), Li, Y. (Author), Liu, J. (Author), Liu, L. (Author), Wang, J. (Author), Wu, C. (Author), Xue, L. (Author), Xue, R. (Author), Yao, R. (Author), Zhao, H. (Author), Zhao, X.-A (Author), Zhu, C. (Author), Zhu, L. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
adult
Adult
Article
chronic liver disease
clinical outcome
complication
coronavirus disease 2019
COVID-19
diabetes mellitus
disease association
disease severity
etiology
female
Female
fibrosis
hepatic steatosis index
hospitalization
Hospitalization
human
Humans
liver cirrhosis
Liver Cirrhosis
liver fibrosis
Logistic Models
major clinical study
male
Male
middle aged
Middle Aged
NAFLD Fibrosis Score
nonalcoholic fatty liver
non-alcoholic fatty liver disease
Non-alcoholic Fatty Liver Disease
pathology
Retrospective Studies
retrospective study
risk factor
Risk Factors
severe illness
severity of illness index
Severity of Illness Index
statistical model
virology
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items